相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma
Mai Takeuchi et al.
ANNALS OF HEMATOLOGY (2020)
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study
Yoshitaka Imaizumi et al.
CANCER SCIENCE (2020)
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
Daniel A. Rauch et al.
BLOOD (2019)
Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile
Christiane Querfeld et al.
BLOOD (2019)
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Lucy B. Cook et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy
Lee Ratner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States
Luis Malpica et al.
BLOOD ADVANCES (2018)
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
Keisuke Kataoka et al.
BLOOD (2018)
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies
Pauline Gravelle et al.
ONCOTARGET (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study
H. Fujiwara et al.
BONE MARROW TRANSPLANTATION (2017)
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
Dohee Kwon et al.
HISTOPATHOLOGY (2016)
PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma
Hiroaki Miyoshi et al.
BLOOD (2016)
Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas
Thomas Menter et al.
HUMAN PATHOLOGY (2016)
Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
Ken Hatogai et al.
ONCOTARGET (2016)
HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)
Keiko Yasuma et al.
PLOS PATHOGENS (2016)
PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma
Wei Zhang et al.
CANCER MEDICINE (2016)
PD-L1 Status in Refractory Lymphomas
Semir Vranic et al.
PLOS ONE (2016)
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu et al.
BLOOD (2015)
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
Haiming Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
Z-Z Yang et al.
BLOOD CANCER JOURNAL (2015)
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)
Takuya Fukushima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Expression of Programmed Death-1 in Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma, Cutaneous Pseudo-T-Cell Lymphoma, and Other Types of Cutaneous T-Cell Lymphoma
Fatma Cetinozman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Differential Expression of Programmed Death-1 (PD-1) in Sezary Syndrome and Mycosis Fungoides
Fatma Cetinozman et al.
ARCHIVES OF DERMATOLOGY (2012)
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study
Takashi Ishida et al.
BLOOD (2012)
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
Junya Kanda et al.
BLOOD (2012)
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
Alan G. Ramsay et al.
BLOOD (2012)
Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma
Bill G. Richendollar et al.
HUMAN PATHOLOGY (2011)
Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
Masakatsu Hishizawa et al.
BLOOD (2010)
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox et al.
BLOOD (2009)
Programmed death 1 is a marker of angioimmunoblastic T-Cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia
Luc Xerri et al.
HUMAN PATHOLOGY (2008)
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
DM Dorfman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
分享论文
